Inventor · disambiguated record
Christopher F. Claiborne
Also filed as: CLAIBORNE CHRISTOPHER · CLAIBORNE CHRISTOPHER F
37 granted patents·6 pending applications·542 citations·filing 1994–2024
98Inventor score
Files withMILLENNIUM PHARM INC19MERCK & CO INC14CLAIBORNE CHRISTOPHER F2ORE PHARMACEUTICALS INC2SCRIPPS RESEARCH INST2
Top patents by PatentIndex Score
43 records- 0197US8008307B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2007·Granted Aug 30, 2011·25 cites·17 claims
- 0296US7572784B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2005·Granted Aug 11, 2009·38 cites·20 claims
- 0395US8481550B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesCLAIBORNE CHRISTOPHER F·Filed 2011·Granted Jul 9, 2013·19 cites·14 claims
- 0494US10836766B2Aurora kinase inhibitors for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2018·Granted Nov 17, 2020·5 cites·5 claims
- 0594US9150525B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2014·Granted Oct 6, 2015·10 cites·19 claims
- 0694US8026246B2Aurora kinase inhibitors for inhibiting mitotic progressionMILLENNIUM PHARMACEUTICIALS INC·Filed 2007·Granted Sep 27, 2011·31 cites·4 claims
- 0794US7718648B2Pyridobenzazepine compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2007·Granted May 18, 2010·15 cites·50 claims
- 0893US9765076B2Aurora kinase inhibitors for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2014·Granted Sep 19, 2017·13 cites·7 claims
- 0993US9765078B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2015·Granted Sep 19, 2017·11 cites·18 claims
- 1092US9102678B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2012·Granted Aug 11, 2015·13 cites·20 claims
- 1191US7935694B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted May 3, 2011·8 cites·22 claims
- 1290US7459448B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2005·Granted Dec 2, 2008·8 cites·22 claims
- 1390US6316474B12-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonistsMERCK & CO INC·Filed 2000·Granted Nov 13, 2001·43 cites·13 claims
- 1488US9988384B2Aurora kinase inhibitors for inhibiting mitotic progressionCLAIBORNE CHRISTOPHER F·Filed 2011·Granted Jun 5, 2018·8 cites·19 claims
- 1588US9458108B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2015·Granted Oct 4, 2016·3 cites·18 claims
- 1687US7592360B23-fluoro-piperidines as NMDA/NR2B antagonistsMERCK & CO INC·Filed 2004·Granted Sep 22, 2009·18 cites·32 claims
- 1787US2024083906A1Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2023·Application pending·0 cites
- 1886US2024400567A1Aurora kinase inhibitors for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2024·Application pending·0 cites
- 1985US6376530B1Cyclic amidines useful as NMDA NR2B antagonistsMERCK & CO INC·Filed 2000·Granted Apr 23, 2002·22 cites·17 claims
- 2083US7053089B2N-substituted nonaryl-heterocyclic NMDA/NR2B antagonistsMERCK & CO INC·Filed 2002·Granted May 30, 2006·13 cites·40 claims
- 2182US6319944B1Aryl amidines, compositions containing such compounds and methods of useMERCK & CO INC·Filed 2000·Granted Nov 20, 2001·21 cites·22 claims
- 2281US6083949ASubstituted imidazoles having anti-cancer and cytokine inhibitory activityMERCK & CO INC·Filed 1998·Granted Jul 4, 2000·28 cites·15 claims
- 2379US10414770B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2017·Granted Sep 17, 2019·1 cites·4 claims
- 2478US7217716B2N-substituted nonaryl-heterocyclic NMDA/NR2B antagonistsMERCK & CO INC·Filed 2002·Granted May 15, 2007·8 cites·9 claims
- 2577US7259157B2N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B AntagonistsMERCK & CO INC·Filed 2002·Granted Aug 21, 2007·12 cites·16 claims
- 2677US6194458B1Benzamide potassium channel inhibitorsMERCK & CO INC·Filed 1999·Granted Feb 27, 2001·43 cites·19 claims
- 2777US2022041605A1Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2021·Application pending·0 cites
- 2876US11014928B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2019·Granted May 25, 2021·0 cites·4 claims
- 2976US6632836B1Carbocyclic potassium channel inhibitorsMERCK & CO INC·Filed 1999·Granted Oct 14, 2003·45 cites·23 claims
- 3075US11958855B2Aurora kinase inhibitors for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2020·Granted Apr 16, 2024·0 cites·10 claims
- 3175US6303637B1Heterocyclic potassium channel inhibitorsMERCK & CO INC·Filed 1999·Granted Oct 16, 2001·39 cites·11 claims
- 3271US6767908B2Substituted imidazoles having cytokine inhibitory activityMERCK & CO INC·Filed 2000·Granted Jul 27, 2004·4 cites·3 claims
- 3371US5481007ATaxoid synthesisSCRIPPS RESEARCH INST·Filed 1994·Granted Jan 2, 1996·11 cites·2 claims
- 3469US6207687B1Substituted imidazoles having cytokine inhibitory activityMERCK & CO INC·Filed 1999·Granted Mar 27, 2001·21 cites·4 claims
- 3567US9718788B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2016·Granted Aug 1, 2017·0 cites·1 claims
- 3666US7723352B2Isoquinolinone potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2004·Granted May 25, 2010·2 cites·8 claims
- 3761US7375125B2Melanocortin-4 receptor binding compounds and methods of use thereofORE PHARMACEUTICALS INC·Filed 2003·Granted May 20, 2008·1 cites·30 claims
- 3860US6291457B1Compounds having cytokine inhibitory activityMERCK & CO INC·Filed 2000·Granted Sep 18, 2001·1 cites·13 claims
- 3959US2012178739A1Lactam compounds useful as protein kinase inhibitorsBLACKBURN CHRISTOPHER·Filed 2012·Application pending·0 cites
- 4055US2008269217A1Melanocortin-4 receptor binding compounds and methods of use thereofORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4152US2011039820A1Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 4242US8338449B2Isoquinolinone potassium channel inhibitorsTROTTER B WESLEY·Filed 2010·Granted Dec 25, 2012·0 cites·17 claims
- 4340US5760240ATaxoid synthesisSCRIPPS RESEARCH INST·Filed 1995·Granted Jun 2, 1998·2 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →